MedTrace Logo

Colorado-Oregon Altitude Study

NCT05734716 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2023-03-10

No results posted yet for this study

Summary

Investigating the utility of prophylactic treatment with iron sucrose and/or erythropoietin on the prevention of acute mountain sickness in fit, young, healthy individuals.

Conditions

  • Acute Mountain Sickness

Interventions

DRUG

Erythropoietin

use of erythropoietin to stimulate red blood cell development prior to ascent to altitude

DRUG

Iron sucrose (Venofer)

use of iron sucrose to stimulate red blood cell development prior to ascent to altitude

DRUG

Sterile Sodium Chloride

sham treatment with sterile saline

Sponsors & Collaborators

  • University of Oregon

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-17
Primary Completion
2022-08-01
Completion
2023-01-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05734716 on ClinicalTrials.gov